{"id":"NCT02643082","sponsor":"Pearl Therapeutics, Inc.","briefTitle":"A Study to Assess the Effects of PT003 and Placebo MDI on Specific Image Based Airway Volumes and Resistance in Subjects With Moderate to Severe COPD","officialTitle":"A Randomized, Double-Blind, Two Treatment, Two Period, Chronic Dosing (2 Weeks), Cross-Over, Single-Center Study to Evaluate the Effects of PT003 and Placebo MDI on Specific Image Based Airway Volumes and Resistance in Subjects With Moderate to Severe COPD","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2015-12-23","primaryCompletion":"2017-01-26","completion":"2017-01-26","firstPosted":"2015-12-30","resultsPosted":"2019-03-19","lastUpdate":"2019-03-19"},"enrollment":20,"design":{"allocation":"RANDOMIZED","model":"CROSSOVER","masking":"TRIPLE","primaryPurpose":"TREATMENT"},"conditions":["COPD"],"interventions":[{"type":"DRUG","name":"GFF MDI (PT003) 14.4/9.6μg","otherNames":["GFF"]},{"type":"DRUG","name":"Placebo MDI","otherNames":["Placebo"]}],"arms":[{"label":"GFF MDI, 14.4/9.6μg","type":"EXPERIMENTAL"},{"label":"Placebo MDI","type":"PLACEBO_COMPARATOR"}],"summary":"Study to Evaluate the Effects of PT003 and Placebo MDI on Specific Image Based Airway Volumes and Resistance With Moderate to Severe COPD.","primaryOutcome":{"measure":"Specific Airway Volume (siVaw)","timeFrame":"Day 15","effectByArm":[{"arm":"GFF MDI 14.4/9.6 µg","deltaMin":1.79,"sd":null},{"arm":"Placebo MDI","deltaMin":1.02,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.0001"}]},"eligibility":{"minAge":"40 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":5,"exclusionCount":7},"locations":{"siteCount":1,"countries":["Belgium"]},"refs":{"pmids":["30214185"],"seeAlso":["http://filehosting.pharmacm.com/DownloadService.ashx?client=CTR_MED_7111&studyid=4142&filename=PT003018-Protocol-Redacted%20updated%20with%20coverpage%20PDFA.pdf","http://filehosting.pharmacm.com/DownloadService.ashx?client=CTR_MED_7111&studyid=4142&filename=PT003018-Protocol-Redacted%20updated%20with%20coverpage%20PDFA.pdf","http://filehosting.pharmacm.com/DownloadService.ashx?client=CTR_MED_7111&studyid=4142&filename=PT003018-12-1-09-statistical-methods-and-analysis-sap_Redacted%2020180524.pdf","http://filehosting.pharmacm.com/DownloadService.ashx?client=CTR_MED_7111&studyid=4142&filename=PT003018%20updated%20statistical-methods-and-analysis-sap_Redacted%2020180924.pdf","http://filehosting.pharmacm.com/DownloadService.ashx?client=CTR_MED_7111&studyid=4142&filename=PT003018%20Protocol%20Cover%20page%20updated%2020180924.pdf","http://filehosting.pharmacm.com/DownloadService.ashx?client=CTR_MED_7111&studyid=4142&filename=PT003018-12-1-09-statistical-methods-and-analysis-sap-Redacted-PDFA.pdf","http://filehosting.pharmacm.com/DownloadService.ashx?client=CTR_MED_7111&studyid=4142&filename=PT003018-Protocol-Redacted-PDFA.pdf","http://filehosting.pharmacm.com/DownloadService.ashx?client=CTR_MED_7111&studyid=4142&filename=PT003018-02MAY2016-Protocol-Redacted-PDFA.pdf"]},"adverseEventsSummary":{"seriousAny":{"events":2,"n":20},"commonTop":["Dyspnoea exertional","Headache","Tremor","Dyspnoea","Dizziness"]}}